Chuck Ence News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Chuck ence. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Chuck Ence Today - Breaking & Trending Today

Parsons Capital Management Inc. RI Sells 24,241 Shares of Relmada Therapeutics, Inc. (NASDAQ:RLMD)

Parsons Capital Management Inc. RI reduced its stake in Relmada Therapeutics, Inc. (NASDAQ:RLMD – Free Report) by 2.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 949,841 shares of the company’s stock after selling 24,241 shares during […] ....

Maged Shenouda , Blackrock Inc , Parsons Capital Management Inc , Relmada Therapeutics Inc , Renaissance Technologies , Exchange Commission , Millennium Management , Parsons Capital Management , Relmada Therapeutics , Free Report , Capital Management , Alto Investors , Sigma Investments , Chuck Ence , Relmada Therapeutics Daily , Nasdaq Rlmd , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Silverarc Capital Management LLC Makes New $300,000 Investment in Relmada Therapeutics, Inc. (NASDAQ:RLMD)

Silverarc Capital Management LLC acquired a new position in shares of Relmada Therapeutics, Inc. (NASDAQ:RLMD – Free Report) in the 3rd quarter, Holdings Channel.com reports. The firm acquired 100,000 shares of the company’s stock, valued at approximately $300,000. Other institutional investors and hedge funds have also recently added to or reduced their stakes in the […] ....

Maged Shenouda , Holdings Channel , Tortoise Investment Management , Relmada Therapeutics Inc , Silverarc Capital Management , Barclays Plc , Bedel Financial Consulting Inc , Securities Exchange Commission , Boothbay Fund Management , Relmada Therapeutics , Free Report , Financial Consulting , Financial Advisors , Fund Management , Investment Management , Exchange Commission , Chuck Ence , Visit Holdingschannel , Relmada Therapeutics Daily , Nasdaq Rlmd , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Chuck Ence Purchases 14,500 Shares of Relmada Therapeutics, Inc. (NASDAQ:RLMD) Stock

Relmada Therapeutics, Inc. (NASDAQ:RLMD – Get Free Report) insider Chuck Ence bought 14,500 shares of the stock in a transaction dated Tuesday, January 30th. The stock was purchased at an average cost of $3.87 per share, for a total transaction of $56,115.00. Following the acquisition, the insider now owns 25,300 shares of the company’s stock, […] ....

Relmada Therapeutics Inc , Blackrock Inc , Millennium Management , Relmada Therapeutics Company Profile , Renaissance Technologies , Securities Exchange Commission , Relmada Therapeutics , Get Free Report , Chuck Ence , Exchange Commission , Therapeutics Trading Down , Alto Investors , Sigma Investments , Relmada Therapeutics Daily , Nasdaq Rlmd , Insider Trading , Nsider Trades ,